A Multicenter Survey of the Indications for Esophagogastroduodenoscopy (EGD)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2287 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-12-24

Study Completion Date

2019-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Esophagogastroduodenoscopy (EGD) become more and more common in diagnosing gastroenterology diseases. The investigators want to find which symptoms can support for positive endoscopic findings through this multicenter study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Esophagogastroduodenoscopy (EGD) become more and more common in diagnosing gastroenterology diseases. And there are indications for EGD. Here, investigators want to find which symptoms can strongly support for positive endoscopy findings. So, investigators design the study to record the symptoms in detail and diagnosis, and then analysis symptoms and the rate of endoscopic findings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digestive System Abnormalities Endoscopy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Esophagogastroduodenoscopy Paediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All of the patients need esophagogastroduodenoscopic procedures

Exclusion Criteria

* Patients whose parents reject to provide information for study

Minimum Eligible Age

1 Day

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ying HUANG

The director of gastroenterology of Children's Hospital of Fudan University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ying Huang, doctor

Role: STUDY_DIRECTOR

Children's Hospital of Fudan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's hospital of Fudan Universtity

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

References

Explore related publications, articles, or registry entries linked to this study.

Wang S, Qiu X, Chen J, Mei H, Yan H, You J, Huang Y. Pediatric esophagogastroduodenoscopy in china: indications, diagnostic yield, and factors associated with findings. BMC Pediatr. 2022 Sep 2;22(1):522. doi: 10.1186/s12887-022-03558-x.

Reference Type DERIVED

PMID: 36056317 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

fudanU-E2

Identifier Type: -

Identifier Source: org_study_id